37 studies found for:    " August 29, 2012":" September 28, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Recruiting Evaluating a Structural and Behavioral HIV Risk Reduction Program for Black Men
Condition: HIV
Interventions: Behavioral: MEN Count;   Behavioral: Comparison
22 Completed Observational Study of Male Circumcision Using PrePex Device
Condition: HIV
Intervention: Device: PrePex device for male circumcision
23 Recruiting Immune Reconstitution in HIV Disease (IREHIV)
Condition: HIV Infection
Interventions: Drug: vitamin D (cholecalciferol) and PBA (sodium phenylbutyrate);   Drug: Placebo tablets
24 Recruiting Integrated Care Centers to Improve HIV Outcomes in Vulnerable Indian Populations
Condition: HIV Infection
Intervention: Behavioral: Integrated care centers
25 Terminated Pharmacology of Antimalarial Therapy With or Without Antiretroviral Therapy
Conditions: HIV Infection;   Malaria
Intervention: Drug: Artemether/Lumefantrine (AL)
26 Completed Economic, Clinical and Quality of Life Assessment in Patients on Antiretroviral Therapy
Condition: HIV
Interventions: Drug: Tenofovir;   Drug: Zidovudine
27 Completed Safety and Efficacy of the PrePex Device Circumcision When Performed by Nurses
Conditions: Circumcision Adult;   HIV CDC Category B2
Intervention: Device: PrePex™ device
28 Completed Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART)
Condition: HIV-1 Infection
Interventions: Drug: Part A: lenalidomide dose escalation;   Drug: Part B: lenalidomide;   Drug: Part B: lenalidomide placebo
29 Unknown  A Phase II Trial to Assess the Safety and Immunogenicity of DNA Priming Administered by the ID Zetajet® With or Without ID Derma Vax™ Electroporation Followed by IM MVA Boosting in Healthy Volunteers in Tanzania and Mozambique
Conditions: Vaccines;   HIV;   Safety;   Immunogenicity
Interventions: Biological: HIVIS DNA vaccine;   Device: Zetajet;   Device: Derma Vax Electroporation;   Biological: Modified Vaccinia Ankara (MVA-CDMR)
30 Recruiting Rifampin and Nevirapine Interactions in Young Children
Conditions: Tuberculosis;   HIV
Intervention:
31 Recruiting Management of Highly Active Anti-retroviral Therapy-related Hyperlipidemia Among HIV-infected Patients in Taiwan
Condition: HIV
Intervention:
32 Unknown  A Study to Assess Cerebrospinal Fluid INflammatory Markers After Addition of Maraviroc to MONotherapy Darunavir/Ritonavir - The CINAMMON Study
Condition: HIV
Intervention: Drug: maraviroc
33 Active, not recruiting Rapid Initiation of Antiretroviral Therapy to Promote Early HIV/AIDS Treatment in South Africa (RapIT Study)
Condition: HIV
Intervention: Other: Rapid ART initiation
34 Unknown  A Pilot Study to Assess the Feasibility of Switching, Individuals Receiving Atripla With Continuing Central Nervous System (CNS) Toxicity, to a Fixed Dose Combination of Tenofovir/Emtricitabine/Rilpivirine
Condition: HIV
Intervention: Drug: tenofovir/emtricitabine/rilpivirine
35 Completed Safety Sudy of Atazanavir Capsules in the Treatment of HIV in Patients Ages 6 - 18 Years
Condition: HIV, Pediatric
Interventions: Drug: Atazanavir;   Drug: Ritonavir
36 Recruiting Screening, Brief Intervention, and Referral to Treatment for Offenders
Conditions: Substance Use;   HIV Infections
Interventions: Behavioral: SBIRT;   Behavioral: Control Group
37 Recruiting Protect and Connect: Couple HIV Prevention for Drug Involved Male Offenders
Conditions: Sexually Transmitted Diseases;   Unsafe Sex;   Substance-Related Disorders
Interventions: Behavioral: PACT;   Behavioral: TAU

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-37) Next Page   
Indicates status has not been verified in more than two years